<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03324529</url>
  </required_header>
  <id_info>
    <org_study_id>17-00868</org_study_id>
    <nct_id>NCT03324529</nct_id>
  </id_info>
  <brief_title>Autonomic Modulation in Takotsubo Syndrome</brief_title>
  <official_title>Autonomic Modulation in Takotsubo Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a minimal risk case-controlled single arm intervention study, including 10 patients
      with a prior history of takotsubo and 10-age and sex matched healthy controls. Subjects will
      undergo in laboratory testing to measure autonomic function. They will then undergo a 15-week
      program of device-guided breathing with remote measures of autonomic function obtained at
      home. Analysis will determine the reproducibility of home autonomic measures and the provide
      preliminary data to determine the efficacy of device-guided breathing on autonomic measures
      and quality of life in patients with takotsubo.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>heart rate variability</measure>
    <time_frame>10 Weeks</time_frame>
    <description>Remote heart rate monitoring with an adhesive chest telemetry patch and biosensor wrist watch</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Takotsubo Syndrome</condition>
  <arm_group>
    <arm_group_label>Participants in the NYU takotsubo registry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 patients with a confirmed history of takotsubo syndrome
10 age- and sex-matched healthy controls with no significant history of cardiac or neurological illness</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tako Breath</intervention_name>
    <description>Device guided breathing. A medical device with a computerized control unit, a breathing sensor and a set of earphones with audio-prompts to guide breathing at a slow rate (&lt;10 breaths/min) with prolonged exhalation.</description>
    <arm_group_label>Participants in the NYU takotsubo registry</arm_group_label>
    <other_name>RESPeRATE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed history of takotsubo syndrome

          -  Healthy person with no significant past history of cardiovascular or neurological
             disease such as heart failure or heart attack; people with cardiovascular risk factors
             such as hypertension will be permitted to participate

        Exclusion Criteria:

          -  Pacemaker or defibrillator implanted

          -  Evidence of autonomic neuropathy, alcohol or drug abuse or exposure to neurotoxins
             (chemotherapy).

          -  Diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harmony Reynolds, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harmony Reynolds</last_name>
    <phone>646-501-0302</phone>
    <email>brokenheartstudy@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Harmony Reynolds</last_name>
      <phone>646-501-0302</phone>
      <email>harmony.reynolds@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Harmony Reynolds, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2017</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Takotsubo Cardiomyopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

